Blue Danube Systems First to Demonstrate Benefits of FDD Massive MIMO in Clustered Multi-Sector Deployments
Blue Danube Systems, a provider of intelligent wireless access solutions that help mobile operators address the challenge of explosive data growth, today announced it has successfully expanded the commercial deployment of its massive MIMO solution to multiple clustered cell sites, demonstrating total capacity improvements for directly adjoining sectors on existing LTE networks using current smartphones.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222006158/en/
Blue Danube Systems First to Demonstrate Benefits of FDD Massive MIMO in Clustered Multi-Sector Deployments (Photo: Business Wire)
Despite the prevalent view that Massive MIMO systems will be central to 5G networks, it has not been clearly proven that the technology is deployable beyond isolated high-demand sectors where effects such as adjacent cell interference must be addressed. In fact, common digital-only Massive MIMO implementations typically operate as closed single-sector solutions, spilling unwanted Radio Frequency (RF) energy across cell edges and potentially degrading adjacent sector performance. In contrast, Blue Danube’s approach to Massive MIMO starts by assuring RF array coherency which in conjunction with digital processing uniquely enables the definition, placement and dynamic coordination of high precision beams that can be software engineered to minimize adjacent sector interference and actually improve clustered cell performance.
Using its BeamCraft™ 500 Massive MIMO systems, Blue Danube performed multi-sector beam optimization at two different sites within the FDD-LTE network at a US mobile operator. Leveraging the machine learning intelligence of the cloud-based software platform BeamPlanner™, RF patterns were generated to optimize and coordinate inter-cell and inter-sector performance. Using only two beams, improvements of 1.7 to 2.0X were demonstrated in total downlink capacity over both multi-sector locations. Additionally, critical cell edge locations saw a dramatic 7dB increase in signal quality due to BeamCraft’s precision beam control leading to 1.7X improvement in individual user download speed. Blue Danube further expects capacity improvements of 5X or more by increasing from two to four beams in future trials and will begin operation in March with a second mobile operator at a multi-sector dense urban location.
By combining precise dynamic beam control with open system interfaces, Blue Danube is engineering its Massive MIMO suite of products to interoperate with other industry network resources such as Self Optimized Network (SON), Centralized Radio Access Network (CRAN) and Open Network Application Platform (ONAP) software along with geolocation and mobile application driven analytics. Combined with BeamPlanner, these capabilities enable operators to use intelligence about their network and customer use to deliver the highest level of overall system-wide performance.
“We are excited to be the first in the industry to successfully demonstrate capacity improvement for clustered multi-sector Massive MIMO deployments,” said Mark Pinto, CEO of Blue Danube Systems. “Adding to our recent announcement of the first multi-band Massive MIMO products, we are making available powerful and flexible tools for operators to seamlessly insert 5G-ready technology into their existing LTE networks for substantial system-wide capacity gain.”
“Cell edge performance continues to be a major challenge for pure digital Massive MIMO systems,” said Shiv Panwar, Professor of Electrical Engineering at NYU and Director of the New York State Center for Advanced Technology in Telecommunications (CATT). “This is the very first demonstration of Massive MIMO performance in a clustered deployment. Blue Danube’s multi-sector BeamCraft results are very exciting and demonstrate that Massive MIMO is now viable for wide-scale adoption in FDD networks.”
“Until now, we have only seen Massive MIMO deployed on individual sectors, not on multiple sectors facing each other,” said Joe Madden, Founder and Principal Analyst at Mobile Experts. “Blue Danube’s results on clustered Massive MIMO deployments represent a critical milestone, provide compelling evidence that the technology can have broad impact across entire operator networks.”
About Blue Danube Systems
Blue Danube Systems is a privately held start-up backed by Sequoia Capital and Silver Lake along with other investors including AT&T. Blue Danube’s unique, award-winning technology combines intelligent software and hardware into a Massive MIMO solution that enables a significant increase in network capacity, utilizing existing infrastructure and today’s mobile devices. For more information, please visit www.bluedanube.com
Blue Danube Participation at Mobile World Congress 2018
Blue Danube will have representatives at Mobile World Congress from February 26 through March 1 in Barcelona. Blue Danube can be found in Hall 2, hospitality stand 2L10.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 21:28 | Tiedote
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 19:05 | Tiedote
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 15:52 | Tiedote
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 15:50 | Tiedote
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 15:46 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 15:00 | Tiedote
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme